S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
NYSE:EHC

Encompass Health (EHC) Stock Forecast, Price & News

$64.09
+0.37 (+0.58%)
(As of 05/13/2022 07:00 PM ET)
Add
Compare
Today's Range
$63.74
$64.74
50-Day Range
$62.26
$74.28
52-Week Range
$56.31
$88.13
Volume
379,100 shs
Average Volume
848,112 shs
Market Capitalization
$6.40 billion
P/E Ratio
16.39
Dividend Yield
1.75%
Beta
0.95
30 days | 90 days | 365 days | Advanced Chart
Receive EHC News and Ratings via Email

Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter.

Encompass Health logo

About Encompass Health

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of February 25, 2022, it operated 146 hospitals, 251 home health locations, and 96 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Hospitals
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
42192430
Employees
43,400
Year Founded
1984

Sales & Book Value

Annual Sales
$5.12 billion
Cash Flow
$6.96 per share
Book Value
$24.53 per share

Profitability

Net Income
$412.20 million
Pretax Margin
12.08%

Debt

Price-To-Earnings

Miscellaneous

Free Float
97,108,000
Market Cap
$6.40 billion
Optionable
Optionable

Company Calendar

Ex-Dividend for 4/18 Dividend
3/31/2022
Dividend Payable
4/18/2022
Last Earnings
4/27/2022
Today
5/15/2022
Next Earnings (Estimated)
7/26/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

3.12 out of 5 stars

Medical Sector

7th out of 1,403 stocks

Hospitals Industry

1st out of 5 stocks

Analyst Opinion: 3.6Community Rank: 4.9Dividend Strength: 2.5Insider Behavior: 3.3Valuation: 1.3 5 -4 -3 -2 -1 -













Encompass Health (NYSE:EHC) Frequently Asked Questions

Is Encompass Health a buy right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Encompass Health stock.
View analyst ratings for Encompass Health
or view top-rated stocks.

Are investors shorting Encompass Health?

Encompass Health saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 2,650,000 shares, an increase of 25.6% from the April 15th total of 2,110,000 shares. Based on an average daily trading volume, of 772,000 shares, the days-to-cover ratio is presently 3.4 days. Currently, 2.7% of the shares of the company are short sold.
View Encompass Health's Short Interest
.

When is Encompass Health's next earnings date?

Encompass Health is scheduled to release its next quarterly earnings announcement on Tuesday, July 26th 2022.
View our earnings forecast for Encompass Health
.

How were Encompass Health's earnings last quarter?

Encompass Health Co. (NYSE:EHC) issued its quarterly earnings data on Wednesday, April, 27th. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.93 by $0.04. The business had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.32 billion. Encompass Health had a net margin of 7.51% and a trailing twelve-month return on equity of 17.99%. The company's revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period last year, the firm posted $1.05 earnings per share.
View Encompass Health's earnings history
.

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health announced a quarterly dividend on Thursday, May 5th. Investors of record on Wednesday, July 13th will be paid a dividend of $0.28 per share on Wednesday, July 20th. This represents a $1.12 annualized dividend and a yield of 1.75%. The ex-dividend date is Tuesday, July 12th.
View Encompass Health's dividend history
.

Is Encompass Health a good dividend stock?

Encompass Health pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.75%. The dividend payout ratio of Encompass Health is 28.64%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Encompass Health will have a dividend payout ratio of 24.72% next year. This indicates that Encompass Health will be able to sustain or increase its dividend.
View Encompass Health's dividend history.

What guidance has Encompass Health issued on next quarter's earnings?

Encompass Health issued an update on its FY22 earnings guidance on Wednesday, April, 27th. The company provided earnings per share guidance of $3.83-4.19 for the period, compared to the consensus EPS estimate of $4.11. The company issued revenue guidance of $5.38-5.50 billion, compared to the consensus revenue estimate of $5.45 billion.

What price target have analysts set for EHC?

8 brokers have issued 1-year price objectives for Encompass Health's stock. Their forecasts range from $75.00 to $104.00. On average, they anticipate Encompass Health's share price to reach $84.88 in the next year. This suggests a possible upside of 32.4% from the stock's current price.
View analysts' price targets for Encompass Health
or view top-rated stocks among Wall Street analysts.

Who are Encompass Health's key executives?
Encompass Health's management team includes the following people:
  • Mr. Mark J. Tarr, CEO, Pres & Director (Age 60, Pay $3.04M)
  • Mr. Douglas E. Coltharp, Exec. VP & CFO (Age 59, Pay $1.65M)
  • Mr. John Patrick Darby, Exec. VP, Gen. Counsel & Corp. Sec. (Age 57)
  • Ms. Barbara Ann Jacobsmeyer, Chief Exec. Officer of Home Health & Hospice (Age 56)
  • Ms. Elissa Joy Charbonneau, Chief Medical Officer (Age 62, Pay $676.46k)
  • Mr. Andrew L. Price, Sr. VP & Chief Accounting Officer (Age 54)
  • Mr. Rusty Yeager, Chief Information Officer & Sr. VP
  • Mr. Mark Miller, Sr. VP of Investor Relations & Strategic Planning
  • Ms. Dawn Rock, Chief Compliance Officer
  • Mr. Anthony A. Hernandez, Chief HR Officer (Age 56)
What is Mark Tarr's approval rating as Encompass Health's CEO?

231 employees have rated Encompass Health CEO Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among Encompass Health's employees.

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Salesforce (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

What is Encompass Health's stock symbol?

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

Who are Encompass Health's major shareholders?

Encompass Health's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (10.68%), Vanguard Group Inc. (9.40%), Baupost Group LLC MA (3.01%), Bank of New York Mellon Corp (2.10%), Victory Capital Management Inc. (1.54%) and Dimensional Fund Advisors LP (1.47%). Company insiders that own Encompass Health stock include Andrew L Price, Elissa Joy Charbonneau, Kevin J O'connor and Terrance Williams.
View institutional ownership trends for Encompass Health
.

Which institutional investors are selling Encompass Health stock?

EHC stock was sold by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Mercer Global Advisors Inc. ADV, Group One Trading L.P., Prudential Financial Inc., Great Lakes Advisors LLC, Bahl & Gaynor Inc., Envestnet Asset Management Inc., and Allianz Asset Management GmbH.
View insider buying and selling activity for Encompass Health
or view top insider-selling stocks.

Which institutional investors are buying Encompass Health stock?

EHC stock was acquired by a variety of institutional investors in the last quarter, including Baupost Group LLC MA, Paradice Investment Management LLC, Bank of New York Mellon Corp, Kempen Capital Management N.V., Dimensional Fund Advisors LP, Renaissance Technologies LLC, Leeward Investments LLC MA, and First Trust Advisors LP. Company insiders that have bought Encompass Health stock in the last two years include Kevin J O'connor, and Terrance Williams.
View insider buying and selling activity for Encompass Health
or or view top insider-buying stocks.

How do I buy shares of Encompass Health?

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Encompass Health's stock price today?

One share of EHC stock can currently be purchased for approximately $64.09.

How much money does Encompass Health make?

Encompass Health has a market capitalization of $6.40 billion and generates $5.12 billion in revenue each year. The company earns $412.20 million in net income (profit) each year or $3.909990 on an earnings per share basis.

How many employees does Encompass Health have?

Encompass Health employs 43,400 workers across the globe.

When was Encompass Health founded?

Encompass Health was founded in 1984.

What is Encompass Health's official website?

The official website for Encompass Health is www.healthsouth.com.

How can I contact Encompass Health?

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The company can be reached via phone at (205) 967-7116, via email at [email protected], or via fax at 205-969-4719.

This page was last updated on 5/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.